Kusajili – Clinical trials directory

Result of your search per specialist: Francis J Giles, MD

Woman and Man Max 99 years
Francis J Giles, MD Update Il y a 4 ans

A Phase I/II Study of CP-4055 in Patients With Refractory/Relapsed Hematologic Malignancies Patients with refractory or relapsed hematologic malignancies will receive CP-4055 intravenously(IV) on Day 1-5 every three weeks until complete response or disease worsening/progressing

Country France, Germany, Italy, Norway, United Kingdom, United States
organs None
Specialty None

Closed trial

More information